Completed PHASE2 INTERVENTIONAL 2-arm NCT00706290

Brief CBT for Anxiety and Advanced Cancer

Sponsor: Massachusetts General Hospital

Conditions Anxiety Cancer Cognitive Behavioral Therapy Depression Unspecified Adult Solid Tumor, Protocol Specific

Interventions Brief Cognitive Behavioral Therapy

Updated 5 times since 2017 Last updated: Jun 5, 2014 Started: Apr 30, 2007 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Anxiety and Cancer and is currently completed. Massachusetts General Hospital leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital
National Cancer Institute (NCI)

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States